EcoDrugPlus

Ensembl ID : ENSORLG00000020235
Gene Symbol: -
Cross references: -
485 Possible Orthologues:

Ensembl ID : ENSORLG00000019583
Gene Symbol: -
Cross references: -
264 Possible Orthologues:

Ensembl ID : ENSORLG00000026588
Gene Symbol: -
Cross references: -
428 Possible Orthologues:

Ensembl ID : ENSORLG00000026712
Gene Symbol: -
Cross references: -
243 Possible Orthologues:

Ensembl ID : ENSORLG00000026061
Gene Symbol: -
Cross references: -
143 Possible Orthologues:

Ensembl ID : ENSORLG00000029058
Gene Symbol: -
Cross references: -
133 Possible Orthologues:

Ensembl ID : ENSORLG00000006948
Gene Symbol: -
Cross references: -
121 Possible Orthologues:

Ensembl ID : ENSORLG00000015604
Gene Symbol: -
Cross references: -
393 Possible Orthologues:

Ensembl ID : ENSORLG00000003888
Gene Symbol: -
Cross references: -
162 Possible Orthologues:

Ensembl ID : ENSORLG00000028442
Gene Symbol: -
Cross references: -
332 Possible Orthologues:

Ensembl ID : ENSORLG00000012571
Gene Symbol: -
Cross references: -
221 Possible Orthologues:

Ensembl ID : ENSORLG00000012904
Gene Symbol: -
Cross references: -
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).